2011 - ISBTS 2011 Symposium


Oral Communications 2: Ischemia / Reperfusion

4.108 - High incidence of intestinal failure after short warm ischemia of the graft in experimental small bowel transplantation

Presenter: Tommaso, Dominioni, Pavia, Italy
Authors: Mario Alessiani1, Lorenzo Cobianchi1, Sandro Zonta1, Jacopo ViganĂ²1, Tommaso Dominioni1, Patrizia Morbini2, Andrea Bottazzi3, Paolo Dionigi1


108
High incidence of intestinal failure after short warm ischemia of the graft in experimental small bowel transplantation

Mario Alessiani1, Lorenzo Cobianchi1, Sandro Zonta1, Jacopo ViganĂ²1, Tommaso Dominioni1, Patrizia Morbini2, Andrea Bottazzi3, Paolo Dionigi1

1Surgery, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy; 2Pathology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; 3Anesthesiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

An increasing number of patients are listed for intestinal (isolated or combined with other organs) transplantation. Consideration for extended donor criteria has been suggested to increase donation. Living intestine donation, extention of acceptable donor criteria, optimized donor allocation and donation after cardiac death (NHB) are taken into consideration for this purpose.

We have studied, in an experimental setting of small bowel transplantation, the feasibility of using intestinal grafts undergoing a short warm ischemia time before cold perfusion, mimicking NHB donors. 25 Large White piglets underwent total orthotopic small bowel transplantation and were randomly divided into two groups: group 1 (n=15) received grafts after 20 minutes of warm ischemia followed by cold perfusion; group 2 (n=10) received grafts after conventional cold perfusion. In both groups immunosuppression was based on tacrolimus oral monotherapy. The animals were observed for 30 days. Postoperative studies included evaluation of graft absorptive function (D-xylose test), histological investigation with sequential biopsies, blood levels monitoring of inflammatory cytokines. The median survival was 19,2 ±9,7 days in group 1 and26,8 ±7,5 in group 2. Intestinal failure was seen only in group 1, causing the death of 40% of animals. The histological examination revealed a statistically significant difference between the two groups in terms of ischemia/reperfusion injury (IRI) (Park/Chiu score, p<0,05). The cytokines blood levels were significantly increased in group 1. In this latter group intestinal absorption was also impaired.

Our study confirm that intestinal mucosa is very sensitive to warm ischemic injury and that, without any treatment to reduce graft IRI, NHB donation is not feasible for small bowel transplantation. However our findings indicate that protective strategies against IRI could be effective to reduce or prevent irreversibile damage due to warm ischemia and are under evaluation in our experimental model. 


You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi